Gastrointestinal Norovirus Infection Associated With Exacerbation of Inflammatory Bowel Disease

被引:76
作者
Khan, Raheel R. [1 ]
Lawson, April D. [1 ]
Minnich, Linda L. [2 ]
Martin, Kathleen [1 ]
Nasir, Amana [1 ]
Emmett, Mary K. [3 ]
Welch, Christine A. [3 ]
Udall, John N., Jr. [1 ]
机构
[1] W Virginia Univ, Hlth Sci Ctr, Dept Pediat, Charleston, WV USA
[2] Charleston Area Med Ctr, Virol Lab, Charleston, WV USA
[3] Charleston Area Med Ctr, Hlth Educ & Res Inst, Charleston, WV USA
关键词
Crohn disease; Gastroenteritis; Inflammatory bowel disease; Norovirus; Ulcerative colitis; CLOSTRIDIUM-DIFFICILE; ULCERATIVE-COLITIS; GASTROENTERITIS; VIRUS; OUTBREAKS; EXCRETION; CHILDREN;
D O I
10.1097/MPG.0b013e31818255cc
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
Objective: In this study we aimed to determine, in pediatric patients, whether norovirus infection could be associated with exacerbations of inflammatory bowel disease (IBD) and ascertain whether the clinical expression of norovirus gastroenteritis was similar in patients with IBD compared with non-IBD controls. Materials and Methods: We performed a case-control retrospective chart review, over a 10-month interval, of patients with IBD with an exacerbation of their disease. The presence of norovirus in stool and/or rectal swab samples, as determined by an enzyme-linked immunoassay, was assessed. In addition, sex, age, type of IBD, presence or absence of diarrhea, hematochezia, and the need for hospitalization were determined. A similar number of control patients who did not have IBD were used as controls. Results: Nine patients with IBD (8 ulcerative colitis/I Crohn disease) had exacerbations with diarrhea. Eight had norovirus antigen in at least I sample. All 9 patients with IBD presented with bloody diarrhea and 6 of the 8 norovirus-positive patients with IBD required hospitalization. All of the control patients experienced diarrhea; however, no hematochezia was noted and no hospitalization was required. Several patients with IBD and controls remained positive for norovirus months after the initial positive stool and/or rectal swab sample. The virus appeared to be more common during winter months. Conclusions: We conclude that norovirus may be associated with exacerbations of IBD. When norovirus accompanies IBD it is more likely to be associated with hematochezia than when the infection occurs in the absence of IBD. JPGN 48:328-333, 2009.
引用
收藏
页码:328 / 333
页数:6
相关论文
共 20 条
[1]   Excess hospitalisation burden associated with Clostridium difficile in patients with inflammatory bowel disease [J].
Ananthakrishnan, A. N. ;
McGinley, E. L. ;
Binion, D. G. .
GUT, 2008, 57 (02) :205-210
[2]  
BERK T, 1985, AM J GASTROENTEROL, V80, P355
[3]  
*CDC, NOR TECHN FACT SHEET
[4]  
COOPER HS, 1977, GASTROENTEROLOGY, V72, P1253
[5]   Asymptomatic and symptomatic excretion of noroviruses during a hospital outbreak of gastroenteritis [J].
Gallimore, CI ;
Cubitt, D ;
du Plessis, N ;
Gray, JJ .
JOURNAL OF CLINICAL MICROBIOLOGY, 2004, 42 (05) :2271-2274
[6]   Norovirus excretion in a healthcare worker without major symptoms of gastroenteritis: infection control implications [J].
Goller, JL ;
Dimitriadis, A ;
Kelly, H ;
Marshall, JA .
AUSTRALIAN AND NEW ZEALAND JOURNAL OF PUBLIC HEALTH, 2004, 28 (01) :88-89
[7]   Impact of Clostridium difficile on inflammatory bowel disease [J].
Issa, Mazen ;
Vijayapal, Aravind ;
Graham, Mary Beth ;
Beaulieu, Dawn B. ;
Otterson, Mary F. ;
Lundeen, Sarah ;
Skaros, Susan ;
Weber, Lydia R. ;
Komorowski, Richard A. ;
Knox, Josh F. ;
Emmons, Jeanne ;
Bajaj, Jasmohan S. ;
Binion, David G. .
CLINICAL GASTROENTEROLOGY AND HEPATOLOGY, 2007, 5 (03) :345-351
[8]   STAT1-dependent innate immunity to a Norwalk-like virus [J].
Karst, SM ;
Wobus, CE ;
Lay, M ;
Davidson, J ;
Virgin, HW .
SCIENCE, 2003, 299 (5612) :1575-1578
[9]  
KRONEMAN A, 2006, EURO SURVEILL 1214, P11
[10]   Enteric virus infections and diarrhea in healthy and human immunodeficiency virus-infected children [J].
Liste, MB ;
Natera, I ;
Suarez, JA ;
Pujol, FH ;
Liprandi, F ;
Ludert, JE .
JOURNAL OF CLINICAL MICROBIOLOGY, 2000, 38 (08) :2873-2877